Healthcare
InnovAge Holding Corp.(INNV)
Live Price
Offline$8.97
-1.97% today
1Y Change
+153.14%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $1.11B
- Revenue Growth
- +11.8%
- EPS Growth
- -37.5%
- Dividend Yield
- 0.0%
Coverage: 251 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
InnovAge Holding Corp. (INNV) is a Healthcare stock with a market cap of $1.11B and listed on NASDAQ. The stock last traded around $8.97 and up 153.1% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +11.8%, EPS growth of -37.5%, a dividend yield of 0.0%. What stands out right now is revenue +11.8%, EPS -37.5%, free cash flow +159.4% with operating margin 0.4% and ROIC 1.0%. Valuation is more restrained than many high-expectation growth names at price/sales 1.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines INNV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.8% vs +7.6% peer median
Operating Margin
Below sector median
+0.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +11.8% and EPS is at -37.5%, with operating margin around 0.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +18.2% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +2.0% | -5.2% | -11.1% |
2026 Feb 3, 2026 | +100.0% | +37.5% | +47.9% | +87.3% |
2025 Nov 4, 2025 | +500.0% | -17.6% | +12.0% | +5.0% |
Benchmark Edge
INNV vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
INNV
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
INNV Max Drawdown
-33.21%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for INNV and SPY.
Company Overview
InnovAge Holding Corp.
NASDAQ Global Select
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
- Leadership
- Patrick Blair
- IPO Date
- Mar 4, 2021
- Employees
- 2.4k
- Street Address
- 8950 East Lowry Boulevard
- Mailing
- Denver, CO, 80230
- Region
- Denver, CO, US
- Reporting Currency
- USD
- Investor Line
- 844 803 8745
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 43.5
- Price/Sales
- 1.2
- Price/Book
- 4.3
Growth
- Revenue
- +11.8%
- EPS
- -37.5%
- Free Cash Flow
- +159.4%
Profitability
- Gross Margin
- 19.8%
- Operating Margin
- 0.4%
- Net Margin
- -0.5%
- ROE
- -1.7%
- ROIC
- 1.0%
Balance Sheet
- Debt/Equity
- 0.46
- Current Ratio
- 1.26
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.